These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4222721)

  • 1. Stimulation of the coronary collateral circulation by lidoflazine (R 7904).
    Schaper WK; Xhonneux R; Jageneau AH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):1-8. PubMed ID: 4222721
    [No Abstract]   [Full Text] [Related]  

  • 2. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary vasodilator responses to hypoxia and induced tachycardia before and after lidoflazine.
    Afonso S
    Am J Physiol; 1969 Feb; 216(2):297-300. PubMed ID: 5766980
    [No Abstract]   [Full Text] [Related]  

  • 5. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary collateral vasodilator action of N-ethoxycarbonyl-3-morpholinosydnonimine (SIN-10) in heart with chronic coronary insufficiency in dogs.
    Hirata M; Kikuchi K
    Jpn J Pharmacol; 1970 Jun; 20(2):187-93. PubMed ID: 5311558
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
    Jageneau A; Schaper W
    Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of lidoflazine in atrial muscle.
    Ilhan M; Kayaalp SO
    Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of adenosine activity by low oral doses of lidoflazine.
    Jageneau AH; Schaper WK
    Nature; 1969 Jan; 221(5176):184-5. PubMed ID: 5782714
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrocardiographic studies on the drug Clinium].
    Széplaki S; Böszörményi E; Werkner J; Szmandra J
    Orv Hetil; 1974 Jan; 115(1):25-8. PubMed ID: 4809138
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological effects on coronary reactive hyperemia in conscious dogs.
    Juhran W; Voss EM; Dietmann K; Schaumann W
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):32-47. PubMed ID: 4252441
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coronary vasodilator agents].
    Nakamura Y
    Kokyu To Junkan; 1974 Sep; 22(9):662. PubMed ID: 4475463
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological aspects of the coronary circulation.
    Parratt JR
    Prog Med Chem; 1969; 6():11-66. PubMed ID: 4307053
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
    Sapozhikov AV
    Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of coronary reactive hyperemia in unanesthetized pigs by an adenosine-potentiator (Lidoflazine).
    Jageneau AH; Schaper WK; Van Gerven W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):16-23. PubMed ID: 4254217
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-homogenous irrigation of the myocardium and its importance in cardiac therapeutics].
    Schaper W
    Brux Med; 1973 Sep; 53(9):523-7. PubMed ID: 4202038
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
    Sano N; Sato S; Hashimoto K
    Jpn J Pharmacol; 1972 Dec; 22(6):857-65. PubMed ID: 4541491
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of various coronary dilators following enteral application in the anesthetized dog].
    Lorenz D; Dell HD
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):272-3. PubMed ID: 4242418
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of carbocromen and of other coronary dilator agents on the blood flow of a myocardial ischemic area].
    Faucon G; Ollagnier M; de Claviere M; Kofman J; Evreux JC
    Therapie; 1975; 30(2):185-95. PubMed ID: 1162641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.